Free shipping in peninsula for orders over 45€

Sign up for our newsletter and get a 10% discount


T-DRAPO study pain osteoporosis

The company Pentalium Pharma is actively working on the research of new therapies for the treatment of specific injuries of the musculoskeletal system. They have recently presented the results of their latest study – T-DRAPO -, which evaluates pain, mobility and joint stiffness in patients with osteoarthritis who have been previously treated with Pentalium CBD.

This is a subjective efficacy study conducted in a sample of 23 patients and with it, they open the way to new clinical studies with cannabidiol.

Other related articles

Abrir chat